• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Vamifeport

CAS No. 2095668-10-1

Vamifeport ( —— )

产品货号. M35124 CAS No. 2095668-10-1

VIT-2763 是具有口服活性的铁转运蛋白 (ferroportin) 的抑制剂,抑制hepcidin 与铁转运蛋白结合,阻滞铁外流。VIT-2763有用于地中海贫血症的潜力。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥1512 有现货
5MG ¥2334 有现货
10MG ¥3674 有现货
25MG ¥6006 有现货
50MG ¥8446 有现货
100MG ¥11093 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Vamifeport
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    VIT-2763 是具有口服活性的铁转运蛋白 (ferroportin) 的抑制剂,抑制hepcidin 与铁转运蛋白结合,阻滞铁外流。VIT-2763有用于地中海贫血症的潜力。
  • 产品描述
    VIT-2763, an oral ferroportin inhibitor, inhibits hepcidin binding to ferroportin and blocks iron efflux. VIT-2763 has the potential in the treatment of β-thalassemia.
  • 体外实验
    VIT-2763 dose dependently reduces the fluorescence polarization signal, indicating that VIT-2763 displaces TMR-hepcidin from ferroportin (IC50 of 24 ± 13 nM).VIT-2763 induces BLA reporter gene activity with an average EC50 of 140 ± 50 nM, as a consequence of increasing intracellular iron concentrations caused by blocked iron export in HEK293 cells.VIT-2763 (100 nM) triggers ubiquitination and subsequent internalization and degradation of ferroportin.Cell Viability Assay.Cell Line:J774 cells. Concentration:100 nM.Incubation Time:10, 20, 40, 60, or 120 minutes.Result:Induced ferroportin internalization and ubiquitination.
  • 体内实验
    VIT-2763 (30, 100 mg/kg, orally twice daily for 36 days) decreases serum iron and prevented liver iron loading in Hbbth3/+ mice.VIT-2763 did not change the total liver iron.VIT-2763 (30, 100 mg/kg, orally twice daily for 36 days) significantly corrects anemia and improved RBC parameters in Hbbth3/+ mice. VIT-2763 decreases the percentage of ROS-positive RBCs in Hbbth3/+ mice from 67% to 30%.VIT-2763 decreases apoptosis and extends the life span of RBCs in Hbbth3/+ mice.Animal Model:Hbbth3/+ mice.Dosage:30, 100 mg/kg.Administration:Orally twice daily for 36 days.Result:Significantly decreased serum iron levels by 77% (30 mg/kg) and 84% (100 mg/kg),Significantly increased Hb levels (as of day 8 of treatment), RBC counts, mean corpuscular Hb concentration (MCHC), and significantly lowered reticulocyte counts, mean corpuscular Hb (MCH), mean corpuscular volume (MCV), and RBC distribution width (RDW) in Hbbth3/+ mice, as compared with the Hbbth3/+ vehicle group.
  • 同义词
    ——
  • 通路
    Apoptosis
  • 靶点
    Ferroptosis
  • 受体
    Ferroptosis
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2095668-10-1
  • 分子量
    408.43
  • 分子式
    C21H21FN6O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 83.33 mg/mL (204.03 mM; 超声助溶 )
  • SMILES
    Fc1cccnc1CNC(=O)c1coc(CCNCCc2nc3ccccc3[nH]2)n1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Vania Manolova, et al. Oral Ferroportin Inhibitor Ameliorates Ineffective Erythropoiesis in a Model of β-Thalassemia. J Clin Invest. 2019 Dec 9;130(1):491-506.?
产品手册
关联产品
  • BCP-T.A

    BCP-T.A,一种杂环亲电子试剂,通过与 GPX4 结合而有效地诱导铁死亡 (ferroptosis)。BCP-T.A 是一种点击化学试剂。它含有 Alkyne 基团,可以和含有 Azide 基团的分子发生铜催化的叠氮-炔环加成反应 (CuAAc)。

  • Cerivastatin

    Cerivastatin 是一种合成的降脂剂,是一种高效,耐受性好,口服活性的 HMG-CoA 还原酶抑制剂,Ki 为 1.3 nM/L。Cerivastatin 可降低低密度脂蛋白胆固醇水平。Cerivastatin 还主要通过 RhoA 抑制作用来抑制 MDA-MB-231 细胞的增殖和侵袭,具有抗癌作用。

  • UAMC-3203 hydrochlor...

    UAMC-3203 盐酸盐是一种有效的选择性铁死亡抑制剂,IC50 为 12 nM。